Amyloidosis Center News

Congratulations to Dr. Gareth Morgan for receiving the Karin Grunebaum Faculty Research Fellowship award.
Join the Amyloidosis Center in congratulating Dr. Gareth, continue with your tremendous work in research.
Structure and Working Modalities of Amyloidosis Centers: ISA Virtual Workshops
ISA Virtual Workshop June 24, 2021 9 AM EDT to 11:00 AM EDT Free, registration required
ACC CardiaCast: Understanding AL and ATTR Cardiac Amyloidosis
In this Podcast, Frederick Ruberg, MD, and Mathew Maurer, MD, discuss key topics in cardiac amyloidosis such as the evolving understanding of the epidemiology of the disease, contemporary approaches to diagnosis with an emphasis on non-invasive means, disease course, and management of heart failure and conduction disease. Click this link to... More
India New England News: Dr. Vaishali Sanchorawala – Woman of the Year 2021
Vaishali Sanchorawla: Her Pioneering Research Into the Rare Disease Amyloidosis Defines the Field
Join Dr. Sanchorawala, Dr. Ruberg, and Lisa Mendelson, NP as they Present an Online Activity
Dr. Vaishali Sanchorawala, Dr. Frederick L Ruberg, and Lisa Mendelson, NP present an online activity titled: Recognizing the Face of Cardiac Amyloidosis: Patient and Provider Perspectives Regarding Diagnosis, Treatment, and Symptom Management For information on how to join in click the link below. https://cme.healio.com/cardiology/20210119/recognizing-the-face-of-cardiac-amyloidosis
New Webinar! ATTR in Primary Care – A Zebra Worth Hunting
Join us live Thursday, Jan 28, 2021, at 2:00 PM EST, when Dr. Frederick Ruberg, senior cardiologist of the Amyloidosis Center (@BU_Amyloidosis) presents on ATTR amyloidosis at the AHA sponsored activity. Click the link to sign up.
Shining a spotlight on race & ethnicity in systemic AL amyloidosis
With an increasingly more diverse profile of patients diagnosed with AL amyloidosis, there is a need to better understand how this unique disease may affect various patient groups differently. Author Andrew Staron Hematology & Oncology Clinical Fellow, Boston University Medical Center Contributing author Vaishali Sanchorawala MD, Boston University School of Medicine
Dr. Sanchorawala speaks on ASCT in AL amyloidosis
Vaishali Sanchorawala The successful use of novel agents and data drawn from the ANDROMEDA trial (NCT03201965) is referenced as to why the utility of ASCT in AL amyloidosis may be questioned. However, Dr Sanchorawala does go on to explain how for a small patient population, ASCT is still a very useful... More
Dr. Sanchorawala presents at the ASH meeting on Hematologic Malignancies: virtual platform
Dr. Vaishali Sanchorawala presents at the ASH Meeting on Hematologic Malignancies: virtual platform on “How I treat systemic AL amyloidosis”.
Farewell to Dr. Shayna Sarosiek
With a mixture of sadness and pride, I would like to inform you that Shayna Sarosiek, MD will be leaving Boston University School of Medicine and Boston Medical Center after 11 years of dedicated service to our patients and center. She has accepted an offer to join Dana Farber Cancer... More